
Finrab L 75mg/20mg Capsule SR
Marketer
Delroy Pharma
Salt Composition
Levosulpiride (75mg) + Rabeprazole (20mg)
Overview Finrab L 75mg/20mg Capsule SR
Gastroesophageal reflux disease (GERD), peptic ulcers, and irritable bowel syndrome may be treated with the prescription medication, Finrab L 75mg/20mg Extended-Release Capsules. This medication lessens excessive stomach acid production and hinders its backflow into the esophagus. Dosage and duration are determined by your physician and should be followed precisely, with or without food. Treatment should continue as directed; premature cessation may lead to symptom recurrence and condition exacerbation. Inform your doctor of all other medications you're using, as interactions are possible. Common side effects include nausea, abdominal pain, diarrhea, gas, constipation, headache, fatigue, and influenza-like symptoms – most are transient. Report any concerning side effects immediately. Dizziness and drowsiness are also possible; avoid driving or mentally demanding tasks until effects are known. Alcohol consumption should be avoided due to potential drowsiness exacerbation. Dietary adjustments (fiber-rich foods, symptom-trigger avoidance), increased hydration, and regular physical activity can enhance treatment outcomes. Prior to commencing treatment, disclose any liver or kidney conditions, pregnancy, pregnancy planning, or breastfeeding to your doctor.
Uses of Finrab L 75mg/20mg Capsule SR
Managing gastroesophageal reflux disease (GERD), intestinal ulcers, and irritable bowel syndrome.
Major Benefits of Finrab L 75mg/20mg Capsule SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the entire capsule without chewing, crushing, or breaking it. Administer Finrab L 75mg/20mg SR capsules on an empty stomach.
Common Side effects of Finrab L 75mg/20mg Capsule SR:
- Nausea
- Stomach pain
- Diarrhea
- Flatulence
- Constipation
- Headache
- Dizziness
- Weakness
- Sleepiness
- Flu-like symptoms
How to use Finrab L 75mg/20mg Capsule SR:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the entire capsule without chewing, crushing, or breaking it. Administer Finrab L 75mg/20mg SR Capsules on an empty stomach.
How Finrab L 75mg/20mg Capsule SR works:
Each Finrab L 75mg/20mg sustained-release capsule contains levosulpiride and rabeprazole, two active pharmaceutical ingredients.
SAFETY ADVICE
AlcoholUNSAFE
Combining Finrab L 75mg/20mg SR capsules with alcohol is not advisable due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
The use of Finrab L 75mg/20mg SR capsules during pregnancy may pose risks. While human research is scarce, animal studies indicate potential harm to a developing fetus. A physician will assess the potential benefits against these risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Finrab L 75mg/20mg sustained-release capsules while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by the side effects of Finrab L 75mg/20mg SR Capsules.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the use of Finrab L 75mg/20mg SR capsules in individuals with renal impairment. Physician consultation is advised. Available evidence, though scant, indicates that administration to such patients should be approached with caution.
LiverCAUTION
Patients with severe hepatic impairment should exercise caution when using Finrab L 75mg/20mg sustained-release capsules. Dosage modification of Finrab L 75mg/20mg sustained-release capsules may be necessary. Physician consultation is advised.
What if you forget to take Finrab L 75mg/20mg Capsule SR :
Should you forget a Finrab L 75mg/20mg Capsule SR dose, take it immediately if remembered. Otherwise, omit the missed dose if your next scheduled dose is imminent; resume your usual dosing regimen. Never take a double dose.
Facts to Know About Finrab L 75mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
